Cargando…
Sentinel lymph node identification by blue dye in patients with breast carcinoma
OBJECTIVE: To determine the diagnostic accuracy of methylene blue dye to detect axillary lymph node metastases in patients with breast carcinoma by taking histopathology as gold standard. METHODS: This quasi experimental study was done at Department of Surgery of Dow University Hospital Karachi duri...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Professional Medical Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859042/ https://www.ncbi.nlm.nih.gov/pubmed/27182259 http://dx.doi.org/10.12669/pjms.322.9563 |
_version_ | 1782430898007834624 |
---|---|
author | Bakhtiar, Nighat Jaleel, Farhat Moosa, Foad Ali Qureshi, Naeem Akhtar Jawaid, Masood |
author_facet | Bakhtiar, Nighat Jaleel, Farhat Moosa, Foad Ali Qureshi, Naeem Akhtar Jawaid, Masood |
author_sort | Bakhtiar, Nighat |
collection | PubMed |
description | OBJECTIVE: To determine the diagnostic accuracy of methylene blue dye to detect axillary lymph node metastases in patients with breast carcinoma by taking histopathology as gold standard. METHODS: This quasi experimental study was done at Department of Surgery of Dow University Hospital Karachi during January 2013 to September 2015 after the approval of Hospital Ethical Committee. A total number of 85 patients with biopsy proven carcinoma were included in the study.1% methylene blue dye was infiltrated in the peri tumoural area of the diseased breast. The blue stained node called sentinel lymph node (SLN) was recognized and carefully dissected out. SLN and mastectomy with axillary clearance specimen was sent for histopathology in two separate bottles and the report of the histopathology was compared. RESULTS: The axillary lymph nodes were positive for carcinoma in 61 cases out of 85(71.7%). Two of the patients had negative sentinel lymph node but positive non sentinel lymph node (false negative), and in three cases sentinel lymph node were involved only but not the rest of the axilla (False positive). The sensitivity, specificity and accuracy were 96.8%,86.36% and 94.1% respectively. CONCLUSION: Methylene blue dye technique is a reliable and safe diagnostic modality for detection of Sentinel lymph node in breast cancer patient because of its high accuracy. |
format | Online Article Text |
id | pubmed-4859042 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Professional Medical Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-48590422016-05-13 Sentinel lymph node identification by blue dye in patients with breast carcinoma Bakhtiar, Nighat Jaleel, Farhat Moosa, Foad Ali Qureshi, Naeem Akhtar Jawaid, Masood Pak J Med Sci Original Article OBJECTIVE: To determine the diagnostic accuracy of methylene blue dye to detect axillary lymph node metastases in patients with breast carcinoma by taking histopathology as gold standard. METHODS: This quasi experimental study was done at Department of Surgery of Dow University Hospital Karachi during January 2013 to September 2015 after the approval of Hospital Ethical Committee. A total number of 85 patients with biopsy proven carcinoma were included in the study.1% methylene blue dye was infiltrated in the peri tumoural area of the diseased breast. The blue stained node called sentinel lymph node (SLN) was recognized and carefully dissected out. SLN and mastectomy with axillary clearance specimen was sent for histopathology in two separate bottles and the report of the histopathology was compared. RESULTS: The axillary lymph nodes were positive for carcinoma in 61 cases out of 85(71.7%). Two of the patients had negative sentinel lymph node but positive non sentinel lymph node (false negative), and in three cases sentinel lymph node were involved only but not the rest of the axilla (False positive). The sensitivity, specificity and accuracy were 96.8%,86.36% and 94.1% respectively. CONCLUSION: Methylene blue dye technique is a reliable and safe diagnostic modality for detection of Sentinel lymph node in breast cancer patient because of its high accuracy. Professional Medical Publications 2016 /pmc/articles/PMC4859042/ /pubmed/27182259 http://dx.doi.org/10.12669/pjms.322.9563 Text en Copyright: © Pakistan Journal of Medical Sciences http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Bakhtiar, Nighat Jaleel, Farhat Moosa, Foad Ali Qureshi, Naeem Akhtar Jawaid, Masood Sentinel lymph node identification by blue dye in patients with breast carcinoma |
title | Sentinel lymph node identification by blue dye in patients with breast carcinoma |
title_full | Sentinel lymph node identification by blue dye in patients with breast carcinoma |
title_fullStr | Sentinel lymph node identification by blue dye in patients with breast carcinoma |
title_full_unstemmed | Sentinel lymph node identification by blue dye in patients with breast carcinoma |
title_short | Sentinel lymph node identification by blue dye in patients with breast carcinoma |
title_sort | sentinel lymph node identification by blue dye in patients with breast carcinoma |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859042/ https://www.ncbi.nlm.nih.gov/pubmed/27182259 http://dx.doi.org/10.12669/pjms.322.9563 |
work_keys_str_mv | AT bakhtiarnighat sentinellymphnodeidentificationbybluedyeinpatientswithbreastcarcinoma AT jaleelfarhat sentinellymphnodeidentificationbybluedyeinpatientswithbreastcarcinoma AT moosafoadali sentinellymphnodeidentificationbybluedyeinpatientswithbreastcarcinoma AT qureshinaeemakhtar sentinellymphnodeidentificationbybluedyeinpatientswithbreastcarcinoma AT jawaidmasood sentinellymphnodeidentificationbybluedyeinpatientswithbreastcarcinoma |